Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to estimate bleeding risk in mild bleeding disorders.

F Rodeghiero1, A Tosetto, G Castaman

  • 1Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy. rodeghiero@hemato.ven.it

Journal of Thrombosis and Haemostasis : JTH
|August 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Thrombopoietin receptor agonists in hereditary thrombocytopenias.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Fifth Åland Island conference on von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Mild bleeding disorders (MBD) present a spectrum of symptoms, often triggered by challenges. Accurate diagnosis is crucial for effective patient treatment and prophylaxis, emphasizing detailed bleeding history and new quantitative tools.

Area of Science:

  • Hematology
  • Genetics
  • Clinical Medicine

Background:

  • Mild bleeding disorders (MBD) are distinct from severe hemophilia, characterized by more frequent/prominent bleeding symptoms than the general population.
  • Bleeding manifestations exist on a continuous spectrum, overlapping with occasional bleeding in individuals without identifiable hemostatic abnormalities.
  • Current diagnostic approaches for MBD face limitations due to scarce clinical data, publication biases, and inconsistent genotype-phenotype correlations.

Purpose of the Study:

  • To identify hemorrhagic disorders fitting the MBD diagnosis that offer a net benefit for patient treatment or prophylaxis.
  • To evaluate the utility of comparing patient phenotype with known nosological entities for MBD diagnosis.
  • To highlight the importance of accurate bleeding history and explore novel diagnostic approaches for MBD.

Related Experiment Videos

Main Methods:

  • Review of principal hemorrhagic disorders to identify potential MBD entities.
  • Comparison of patient phenotype with established nosological entities.
  • Emphasis on the importance of accurate bleeding history and family history.
  • Mention of development of new standardized and quantitative diagnostic tools.
  • Exploration of innovative approaches combining phenotypic and genetic data.

Main Results:

  • A continuous spectrum of bleeding severity exists, making precise categorization challenging.
  • Phenotypic comparison with known entities is useful but limited by data availability and biases.
  • Residual clotting factor activity does not always correlate reliably with bleeding severity.
  • Molecular characterization is often not useful for diagnosis.
  • Accurate bleeding history remains paramount for diagnosis.

Conclusions:

  • Accurate diagnosis of MBD is essential for effective patient management and prophylaxis.
  • Traditional diagnostic methods have limitations, necessitating improved approaches.
  • New standardized, quantitative tools and integrated phenotypic-genetic data hold promise for better bleeding risk assessment in MBD.